Synthetic peptides and methods for treating cancer invasion and metastasis
AssigneeMatthias W. Rath
InventorsShrirang Netke, Aleksandra Niedzwiecki, Matthias Rath
Life of this patent
Estimating the term…
Abstract
The present invention relates to synthetic oligopeptides that exhibit inhibitory activity towards cancer invasion and metastasis. The peptides of the invention comprise PRKPKWDK (SEQ ID:2) peptide corresponding to amino acids of 85 to 92 of the matrix metalloproteinase (MMP-2), and fragments, analogs and homologs. The invention also relates to the uses of such peptides as inhibitory of human cancer invasion and metastasis and further to their therapeutic use in preventing and treating other pathological conditions related to the degradation of extracellular matrix by MMPs.
Claims2
A method for inhibiting invasion of human melanoma cells or human breast cancer cells, comprising treating the human cells with an effective amount of a synthetic oligopeptide where the synthetic oligopeptide is less than 30 residues in length and consists essentially of the amino acid sequence as set forth in SEQ. ID. No. 2.
A method for inhibiting invasion of melanoma cells or breast cancer cells in a human patient, comprising treating said human patient by administering to the patient a pharmaceutical composition comprising an effective amount of a synthetic oligopeptide where the synthetic oligopeptide is less than 30 residues in length and consists essentially of the amino acid sequence shown in SEQ. ID. No. 2, and a pharmaceutical acceptable carrier.
Dependencies are inferred from the claim text.